Novel substituted 4–aminomethylpiperidines as potent and selective human β3–agonists. Part 2: Arylethanolaminomethylpiperidines

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 20, 2002, Pages 2963-2967

  Steffan, Robert J ^a   Ashwell, Mark A ^a   Solvibile, William R ^a   Matelan, Edward ^a   Largis, Elwood ^a   Han, Stella ^a   Tillet, Jeffery ^a   Mulvey, Ruth ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOMETHYLPIPERIDINE; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; ETHANOLAMINOMETHYLPIPERIDINE; ETHYLAMINE; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; MOUSE; NONHUMAN; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION; TRANSGENIC MOUSE;

ADRENERGIC BETA-AGONISTS; ANIMALS; CHO CELLS; CRICETINAE; HUMANS; INDICATORS AND REAGENTS; MICE; MICE, TRANSGENIC; PIPERIDINES; RECEPTORS, ADRENERGIC, BETA-3; STRUCTURE-ACTIVITY RELATIONSHIP;

MUS MUSCULUS;

EID: 0037152418     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00608-X     Document Type: Article

References (11)

1. (a) Dow R.L. Exp. Opin. Invest. Drugs. 6:1997;1811.
2. (b) Strosberg A.D. Annu. Rev. Pharmacol. Toxic. 37:1997;421.
3. Steffan R.J., Ashwell M.A., Solvibile W.R., Matelan E., Largis E., Han S., Tillet J., Mulvey R. Bioor. Med. Chem. Lett. 12:2002;2957.
4. Kajigaeshi S., Kakinami T., Ikeda H., Okamoto T. Chem. Express. 3:1988;659.
5. Corey E.J., Li W., Nagamitsu T. Angew. Chem., Int. Ed. 37:1998;1986.
6. Asselin A.A., Humber L.G., Crosilla D., Oshiro G., Wojdan A., Grimes D., Heaslip R.J., Rimele T.J., Shaw C.C. J. Med. Chem. 29:1986;1009.
7. Spitzer U.A., Stewart R.J. Org. Chem. 39:1974;3936.
8. o-Iodobenzoic acid (IBX) in DMSO Frigerio M., Santagostino M. Tetrahedron Lett. 43:1994;8019.
9. For full experimental details see: Steffan, R. J.; Ashwell M. A.; Solvibile, W. R.; Matelan, E; US21875300P, application submitted July 17, 2000.
10. Susulic V.S., Frederich R.C., Lawitts J., Tozzo E., Kahn B.B., Harper M.-E., Himms-Hagen J., Flier J.S., Lowell B.B. J. Biol. Chem. 270:1995;29483.
11. 125I]iodocyanopindolol with these cells.